<?xml version="1.0" encoding="UTF-8"?>
<p id="p0130">Huge inflammatory response is observed in COVID-19. Anti-inflammatory drugs especially JAK-STAT inhibitors, used against rheumatoid arthritis, may be effective against elevated levels of cytokines and useful in inhibiting viral infection. According to recent study, an inflammatory drug, baricitinib when used in combination with anti-viral drugs like Remidesivir, increases the potential of the drug to reduce viral infection (
 <xref rid="bb0725" ref-type="bibr">Stebbing et al., 2020</xref>).
</p>
